M&A Deal Summary

Cynosure Acquires Eleme Medical

On February 3, 2011, Cynosure acquired medical products company Eleme Medical from L Capital Partners for 5M USD

Acquisition Highlights
  • This is Cynosure’s 3rd transaction in the Medical Products sector.
  • This is Cynosure’s 3rd largest (disclosed) transaction.
  • This is Cynosure’s 1st transaction in the United States.
  • This is Cynosure’s 1st transaction in New Hampshire.

M&A Deal Summary

Date 2011-02-03
Target Eleme Medical
Sector Medical Products
Buyer(s) Cynosure
Sellers(s) L Capital Partners
Deal Type Add-on Acquisition
Deal Value 5M USD

Target

Eleme Medical

Merrimack, New Hampshire, United States
Elemé Medical, Inc. is a venture backed aesthetics company dedicated to providing market-leading technology in all areas of body shaping.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cynosure

Westford, Massachusetts, United States

Category Company
Founded 1991
Sector Medical Products
Employees857
Revenue 433M USD (2016)
DESCRIPTION

Cynosure is a developer and marketer of aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure was founded in 1991 and is based in Westford, Massachusetts.


DEAL STATS #
Overall 3 of 7
Sector (Medical Products) 3 of 6
Type (Add-on Acquisition) 1 of 4
State (New Hampshire) 1 of 1
Country (United States) 1 of 5
Year (2011) 1 of 2
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-07 Suzhou Cynosure Medical Devices

Suzhou, China

Cynosure China engages in the development, manufacture, and marketing of aesthetic treatment systems that are used by physicians and other practitioners to perform noninvasive procedures

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-05 The PinPointe FootLaser

United States

The PinPointe FootLaser is the world's first FDA cleared light-based device for the treatment of Onychomycosis (toenail fungus), a condition that affects approximately 36 million people in the United States and an estimated 10 percent of the population worldwide.

Buy -

Seller(S) 1

SELLER

L Capital Partners

New York, New York, United States

Investor


Category Private Equity Firm
Founded 2004
PE ASSETS 165M USD
Size Small
Type Sector Focused
DESCRIPTION

L Capital Partners is a specialist private equity firm focused on investing in companies operating within the healthcare, technology, and energy/environmental sectors, looking to bring 'groundbreaking products to market'. Within healthcare, L Capital looks to invest in biopharmaceutical and medical device businesses. Within technology, the Firm's emphasis is on security/defense and IT businesses. And within the energy/environmental sector, the L Capital's focus is investing in opportunities that 'improve the quality of life'. L Capital was formed in 2004 and has offices in New York City and Tel Aviv, Israel.


DEAL STATS #
Overall 4 of 7
Sector (Medical Products) 2 of 3
Type (Add-on Acquisition) 2 of 5
State (New Hampshire) 1 of 1
Country (United States) 4 of 7
Year (2011) 1 of 1
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-09 Tengion

Winston-Salem, North Carolina, United States

Tengion, Inc. is a regenerative medicine company, focuses on discovering, developing, manufacturing, and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues to address unmet medical needs in urologic, renal, gastrointestinal and vascular diseases.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-01 OnPATH Technologies

Marlton, New Jersey, United States

Provider of automated connectivity solutions, with a family of enterprise-class physical layer network connectivity switches purchased from Brocade.

Sell $40M